A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis

NCT00440518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Lacosamide
OTHER: Placebo
DRUG: Lacosamide

Sponsor

UCB Pharma